bromodeoxyuridine and Neointima
bromodeoxyuridine has been researched along with Neointima in 5 studies
Research
Studies (5)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Li, W; Liang, C; Shan, Z; Teng, Y; Wang, S; Wang, Z; Yu, J | 1 |
Ikeda, U; Itano, N; Izawa, A; Kashima, Y; Kimata, K; Koyama, J; Nakayama, J; Shiba, Y; Takahashi, M; Taniguchi, S | 1 |
Kibbe, MR; Lee, VR; Martinez, J; Tsihlis, ND; Vavra, AK | 1 |
Fogelstrand, P; Mattsson, E; Mellander, S | 1 |
Braune, M; Glasnov, TN; Groschner, K; Hoefler, G; Kappe, CO; Koenig, S; Maechler, H; Schernthaner, M; Wittchow, E | 1 |
Other Studies
5 other study(ies) available for bromodeoxyuridine and Neointima
Article | Year |
---|---|
Mitoxantrone suppresses vascular smooth muscle cell (VSMC) proliferation and balloon injury-induced neointima formation: An in vitro and in vivo study.
Topics: Angioplasty, Balloon; Animals; Bromodeoxyuridine; Carotid Artery Injuries; Cell Cycle; Cell Proliferation; DNA Replication; DNA Topoisomerases, Type II; Humans; Male; Mitoxantrone; Myocytes, Smooth Muscle; Neointima; Primary Cell Culture; Proto-Oncogene Proteins c-sis; Rats; Rats, Sprague-Dawley; Topoisomerase II Inhibitors | 2017 |
Crucial role of hyaluronan in neointimal formation after vascular injury.
Topics: Analysis of Variance; Animals; Atherosclerosis; Blotting, Western; Bromodeoxyuridine; Cell Movement; Cell Proliferation; Cytokines; DNA Primers; Humans; Hyaluronic Acid; Hymecromone; Immunohistochemistry; Mice; Mice, Transgenic; Microscopy, Confocal; Muscle, Smooth, Vascular; Neointima; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Vascular System Injuries | 2013 |
Nitric oxide is less effective at inhibiting neointimal hyperplasia in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Bromodeoxyuridine; Carotid Arteries; Carotid Artery Injuries; Guanylate Cyclase; Hyperplasia; Hypertension; Macrophages; Neointima; Nitric Oxide; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase | 2013 |
Increased vascular injury reduces the degree of intimal hyperplasia following angioplasty in rabbits.
Topics: Angioplasty, Balloon; Animals; Bromodeoxyuridine; Cell Movement; Connective Tissue; Hyperplasia; Leukocytes; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Rabbits; Tunica Intima | 2011 |
A TRPC3 blocker, ethyl-1-(4-(2,3,3-trichloroacrylamide)phenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate (Pyr3), prevents stent-induced arterial remodeling.
Topics: Antimetabolites; Arteries; Blotting, Western; Bromodeoxyuridine; Calcium Signaling; Cell Proliferation; Cells, Cultured; Coronary Vessels; Graft Occlusion, Vascular; Humans; Hyperplasia; Immunohistochemistry; Isoenzymes; Myocytes, Smooth Muscle; Neointima; Organ Culture Techniques; Pyrazoles; Real-Time Polymerase Chain Reaction; RNA; Stents; Tissue Fixation; TRPC Cation Channels | 2013 |